Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EROAD Limited Director's Dealing 2020

Aug 2, 2020

66188_rns_2020-08-03_db8a17fa-64c9-47b4-a467-b3b818eae61b.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [76 x 28] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: EROAD Limited
Date this disclosure made: 3 August 2020
Date of last disclosure: 5 February2020
Director or senior managergiving disclosure
Full name(s): Michael Bruce Bushby
Name of listed issuer: EROAD Limited
Name of related body corporate (if applicable): Not applicable
Position held in listed issuer: Former Independent Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products: Ordinary shares in EROADLimited(ERD)
Nature of the affected relevant interest(s): Michael Bushby is a director ofLowelly Pty Limited andaccordingly has the power tocontrol dealings and voting ofshares held by Lowelly PtyLimited as trustee of theLowelly Superannuation Fund.Michael Bushby is also abeneficiary of the LowellySuperannuation Fund.
For that relevant interest-
Number held in class before acquisition or disposal: 137,671
Number held in class after acquisition or disposal: 37,671
Current registered holder(s): Lowelly Pty Limited as trusteefor the Lowelly SuperannuationFund.
Registered holder(s) once transfers are registered: Not applicable

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative: Not applicable
Class of underlyingfinancialproducts: Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products(if any): Not applicable
A statement as to whether the derivative is cash settled orphysicallysettled: Not applicable
Maturitydate of the derivative(if any): Not applicable
Expirydate of the derivative(if any): Not applicable
Theprice specified in the terms of the derivative(if any): Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products: Not applicable
_For that derivative,- _
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative: Not applicable

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-Date of transaction:Nature of transaction:Name of anyotherpartyorparties to the transaction(if known):The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value,describe the consideration:Number of financialproducts to which the transaction related:If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details—Whether relevant interests were acquired or disposed of duringa closedperiod:
Date of transaction: 28 July2020
Nature of transaction: On market sale of 100,000EROAD ordinaryshares
Name of anyotherpartyorparties to the transaction(if known): Unknown
The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value,describe the consideration: $336,590.00
Number of financialproducts to which the transaction related: 100,000
If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod: Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod: Not applicable
Date of the prior written clearance(if any): Not applicable

Summary of other relevant interests after acquisition or disposal:

Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
CertificationI certify that, to the best of my knowledge and belief, the information contained in thisdisclosure is correct and that I am duly authorised to make this disclosure by all personsfor whom it is made.Signature of director or officer:Date of signature:orSignature of person authorised to sign on behalf of director or officer:Date of signature:Name and title of authorisedperson:
Signature of person authorised to sign on behalf of director or officer:
Date of signature: 3/08/2020
Name and title of authorisedperson: Mark Heine, General Counsel